Multiple Sclerosis
About Multiple Sclerosis
We have been involved in MS since 2015 through our Assessa PML collaboration with Biogen. Multiple Sclerosis is a condition that affects the brain and spinal cord. It is the most common autoimmune disorder of the central nervous system, affecting around 2.3 million people globally as of 2015. Ongoing research is focused on developing more effective disease-modifying and symptomatic treatments as well as the creation of therapies for the progressive types of MS.
MS specific regional MRI and PET analysis
- Multiple Sclerosis specific validated volumetric image endpoints using IXICO’s proprietary algorithms.
Expert Neuro-radiology
- Team of expert Neuro-radiologists performing centralized, real time, standardised reads.
Digital Biomarker Analysis
- Combining the best emerging wearable technology with our digital platform for analysis of biosensor data in Multiple Sclerosis.
Consultation and Supporting Regulatory Pathway
- Protocol consultation at early stage to support Regulatory pathway.